In this interview, he reflects on the impact and influences of the VinFuture Prize on his further research, as well as the challenges and prospects of expanding GLP-1 accessibility
'I can't afford to lose anymore,' she said
Eli Lilly, which makes the Zepbound injection, applied to the FDA in late 2025 for approval of its competing obesity pill
Maintenance isn't a plateau where nothing changes
12 , 13 , 14 , 15 This is the first comparison of tirzepatide 5, 10 and 15 mg versus injectable semaglutide 2 mg on the change from baseline in HbA1c and body weight in patients with T2D and elevated glucose levels (HbA1c 8%10%) with metformin
Additionally, while analogues remain cytotoxic, the technology remains in the experimental preclinical stage, and issues regarding potential systemic toxicity and precise molecular binding specificity in humans remain unverified (125,129)